Europe adopts compromise position on reduced risk products to beat cancer

The European Parliament has overwhelmingly adopted the Special Committee on Beating Cancer (BECA) report in a move that marks the first time a European institution has formally acknowledged reduced risk products could play a role in smoking cessation – with some caveats.

The parliament voted 652 in favour, 15 against and 27 abstaining during last week’s plenary session. The approved plan included “compromise amendments” on alternatives approved by 29 of 34 committee members in December.

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

Shop reports

Request a free sample of this report:

“ Europe adopts compromise position on reduced risk products to beat cancer ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ Europe adopts compromise position on reduced risk products to beat cancer ”






      The European Parliament has overwhelmingly adopted the Special Committee on Beating Cancer (BECA) report in a move that marks the first time a European institution has formally acknowledged reduced risk products could play a role in smoking cessation – with some caveats.

      The parliament voted 652 in favour, 15 against and 27 abstaining during last week’s plenary session. The approved plan included “compromise amendments” on alternatives approved by 29 of 34 committee members in December.

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik